CSE:CMND -

QQQ $ 491.58 $ -0.16 (-0.03 %)

DIA $ 392.84 $ -0.46 (-0.12 %)

SPY $ 551.46 $ 2.45 (0.45 %)

TLT $ 92.08 $ 0.00 (0 %)

GLD $ 219.89 $ 0.38 (0.17 %)

Previous Close

$ na

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

na - na

Volume

Average Volume

Market Cap

Beta (5Y Monthly)

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na (na)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

SciSparc- Clearmind Collaboration Evolves ...
03/27/2024 12:56:10

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusi...

next-gen-psychedelics-companies-scisparc-and-clearmind-collaboration-file-3-patents

Next-Gen Psychedelics Companies SciSparc A...
02/21/2024 16:12:39

SciSparc & Clearmind file patents for LSD, psilocybin, DMT blends, advancing psychedelic therapeutics for mental health.

Clearmind Medicine Forms A Data And Safety...
04/27/2023 12:40:37

Clearmind Medicine Inc. (NASDAQ:CMND) (CSE:CMND), (FSE: CWY) ("Clearmind" or "the company"), a biotech company ...

scisparc-and-clearmind-collaboration-strengthens-ip-portfolio-with-patent-application-for-treatment-of-depression

SciSparc And Clearmind Collaboration Stren...
04/21/2023 13:12:06

SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to tre...

SciSparc and Clearmind Collaboration Stren...
04/21/2023 12:32:49

The application refers to a novel psychedelic-based combination of Clearmind's MEAI and SciSparc's Cannamide™ TEL AVIV...

Clearmind Medicine Announces Pricing Of $3...
04/04/2023 13:06:17

Clearmind Medicine Inc. (NASDAQ:CMND) (CSE:CMND), (FSE: CWY) ("Clearmind"), a biotech company focused on the discovery ...

psyched-22-states-with-reform-bills-ketamine-therapy-services-today-oscars-on-shrooms--more

Psyched: 22 States With Reform Bills, Keta...
03/20/2023 21:11:05

Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered

scisparc-and-clearmind-reveal-three-unique-combinations-of-future-psychedelic-based-compounds

SciSparc And Clearmind Reveal Three Unique...
02/22/2023 16:06:46

SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to tre...

SciSparc And Clearmind Reveal Three Unique...
02/22/2023 13:07:21

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusi...

Israeli Biotech Clearmind Medicine Announc...
01/31/2023 14:05:10

Clearmind Medicine Inc. (NASDAQ:CMND) (CSE:CMND), (FSE: CWY) ("Clearmind" or "the Company"), a biotech company ...

Israel-Based Clearmind Medicine Successful...
01/10/2023 13:43:59

Clearmind Medicine Inc. (NASDAQ:CMND) (CSE:CMND) (FSE: CWY) ("Clearmind" or the "company"), a biotech company f...

Clearmind Medicine Granted U.S. Patent For...
12/21/2022 14:04:19

Clearmind Medicine Inc. ((Nasdaq, CSE:CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on di...

Clearmind Announces Initiation Of CMND-100...
11/23/2022 13:45:58

Clearmind Medicine Inc. (NASDAQ:CMND), (CSE:CMND), (FSE: CWY) ("Clearmind" or the "Company"), a biotech company...

Clearmind Medicine Priced ~1.15M Share Pub...
11/15/2022 10:26:14

Clearmind Medicine Inc.

scisparc-and-clearmind-partnership-yields-3rd-patent-application-for-the-treating-of-obesity-and-metabolic-syndromes

SciSparc And Clearmind Partnership Yields ...
09/22/2022 16:03:25

SciSparc Ltd. (NASDAQ: SPRC) announced that Clearmind Medicine Inc. (OTCPK:CMNDF) (CSE:CMND) (FSE:CWY0), has filed a provisiona...

SciSparc And Clearmind Medicine Collaborat...
09/22/2022 14:00:15

TEL AVIV, Israel, Sept. 22, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) (“Company” or “SciSparc”), a specialty clinica...

SciSparc Announces Additional Pre-Clinical...
08/24/2022 11:34:18

Results indicate significant decrease in cocaine craving in a sub-group that received the treatment TEL AVIV, Israel, Aug. 24,...

psyched-christies-launches-nft-collection-supporting-psychedelic-science-origins-listing-on-cse-gives-retail-investors-access-to-private-companies

Psyched: Christie's Launches NFT Collectio...
06/08/2022 12:45:50

The world of psychedelics is getting a crossover with another category in the millennial catalog of trendy investments: NFTs.

scisparc--clearmind-medicine-team-up-on-patent-for-psychedelic-combination-to-treat-cocaine-addiction

SciSparc & Clearmind Medicine Team Up On P...
06/02/2022 15:28:39

SciSparc Ltd. (NASDAQ: SPRC) collaboration with Clearmind Medicine Inc. (OTCPK:CMNDF) (CSE:CMND) (FSE:CWY0) resulted in the fil...

Clearmind Medicine and SciSparc Collaborat...
06/02/2022 11:53:25

Clearmind Medicine Inc.

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

07/16/2024 Teladoc Health, Inc. (TDOC)

07/16/2024 Vestis Corporation (VSTS)

07/22/2024 Cambium Networks Corporation (CMBM)

07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)

Search Symbol

Create a Free Account Sign in to your Account Reset Password